We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
Survival analysis data not available.
COLON ADENOCARCINOMA - Protein relative expression (CPTAC)
Number of samples
197
Samples
Sample ID
Sample type
nRPX
8cc7e656-0152-4359-8566-0581c3
Tumor
N/A
5c70e654-583c-4dd3-ad42-0d9b39_D2
Normal
N/A
0065bfd9-e1b9-43a8-9379-9658ba_D3
Tumor
N/A
d8805fa4-30f9-4417-907e-fdc50c_D2
Normal
N/A
58a92726-4d1f-4e44-8938-52b97d_D3
Tumor
N/A
591fb460-703a-437d-8d9a-ff2a35_D3
Tumor
N/A
a90eb718-6a8f-4cbf-89c1-f9e9bd_D2
Tumor
N/A
5a3aa99d-ca10-45f6-939f-12392a_D2
Normal
N/A
8fab37a4-cdf9-4ce8-9081-7b9148_D2
Normal
N/A
6797a69d-2f74-44b9-8147-cd4fac_D2
Normal
N/A
ea6df59d-5240-4927-b19d-d44590_D2
Tumor
N/A
e8faa3a7-9fc7-428e-9334-a0afd0_D3
Tumor
N/A
b2978e90-cd2a-4665-b1bf-508a99_D2
Normal
N/A
e0068ac5-f557-443a-bd4b-bdfcef_D3
Tumor
N/A
2167c594-c33f-4795-b95b-69bd07_D2
Tumor
N/A
16ac8458-5200-4302-9ad0-b311df_D2
Normal
N/A
0784c7b3-e6a4-42a8-9288-eb4ba0_D2
Normal
N/A
64ed43a2-f083-43cb-9d0d-118495_D2
Normal
N/A
9a48cf57-e1f0-4ea1-9804-d563f2_D2
Normal
N/A
d0511ea6-43c3-4c61-b08e-cf49b7_D3
Tumor
N/A
526c3664-5b9b-4a2b-a00e-a14623_D2
Tumor
N/A
7bdfa5c9-d11f-4600-9c44-a87996_D2
Normal
N/A
853ecf90-71e6-4156-a56f-a34b65_D2
Normal
N/A
e070ff10-058b-4733-93ab-bdd702_D2
Normal
N/A
092c5a37-325b-4181-b230-2d8fff_D2
Tumor
N/A
154115ac-2ec2-439d-b55e-0464ee_D2
Normal
N/A
963fc8db-f412-4427-a198-23f660_D2
Normal
N/A
79097be1-cd36-4a23-99d1-3d744f_D2
Tumor
N/A
8b9e4266-7754-4f2c-ac9e-329905_D2
Tumor
N/A
642fc6c3-8d4a-4e3d-ad0a-cc088a_D2
Tumor
N/A
e196a0b4-2a05-43de-bb30-ceb761_D2
Tumor
N/A
54565eae-05c5-4dae-bde9-ae4874_D2
Normal
N/A
f4bccfe4-98d0-466b-a6d7-44341b_D3
Tumor
N/A
47d2a435-b203-4438-ae72-53c424_D2
Normal
N/A
51590333-cfe5-4ce5-b8ff-58fa3c_D2
Normal
N/A
9a6879b1-4f78-4ac6-9fca-dad049_D2
Normal
N/A
f6173181-0993-4a5f-a4cd-5f30b1_D2
Tumor
N/A
bc574f73-89ba-44d7-992e-82622c_D3
Tumor
N/A
82157a70-12f1-4913-b548-d98881_D2
Normal
N/A
573048dd-2502-40e0-8e8c-c41bb8_D3
Tumor
N/A
63c1f7ac-b1ae-4c28-95aa-ce21e5_D2
Normal
N/A
6e20c8e9-ab75-4996-9296-445b00_D2
Tumor
N/A
c7aeb685-31b3-445e-8177-a3e729_D3
Tumor
N/A
8af80ae9-2088-4124-91fb-8d6c17_D3
Tumor
N/A
cd89ffbb-574a-4052-bd9a-00c890_D2
Tumor
N/A
c1b66358-d103-493c-b8ec-92c43b_D1
Tumor
N/A
98742d96-cc2f-43f0-9de2-bc7afe_D3
Tumor
N/A
e3c012aa-51c2-42b0-a478-bd620f_D2
Normal
N/A
ec9afcc4-ccf7-4226-b0e8-d6897d_D3
Tumor
N/A
b2400046-1d25-429d-a821-6040a6
Tumor
N/A
2b810478-7956-4a8b-870d-184859_D2
Tumor
N/A
722378ea-d1a7-4cfc-aca5-ba45f9_D8
Tumor
N/A
42216d99-e8ff-43c9-b6db-28c3a6_D3
Tumor
N/A
87b0e853-43ea-4efb-8a22-dd221f_D2
Normal
N/A
5557e478-3e6f-475b-8acc-1b4159_D8
Tumor
N/A
a2f03d85-5f1a-4b3e-9dbf-74e67e_D3
Tumor
N/A
7fd386f0-e7f6-4ee1-9cd7-b3318a_D2
Normal
N/A
62627b73-1763-48bc-8eea-e5bd76_D2
Normal
N/A
f6b1079b-9d67-4c63-b3d0-d562b5_D2
Tumor
N/A
e2e83b72-b14b-4b06-9461-1115d6_D2
Tumor
N/A
aa0f5b40-3290-4255-8f4d-f45d4e_D3
Tumor
N/A
04ded2cd-3b57-4aec-9c11-48f58e_D2
Normal
N/A
1425a1a1-c835-47a2-a9b9-4db5d0_D8
Tumor
N/A
1c070992-647b-4173-a481-904c4d_D2
Normal
N/A
5de06adb-e00d-4114-8d76-04bd30_D2
Normal
N/A
d7608884-a0d6-4e9e-aac7-6cd813_D3
Tumor
N/A
26acb513-3ffe-49ad-8581-9dfc97_D2
Normal
N/A
c307b7b0-534a-45fa-a420-35f773_D2
Normal
N/A
5e886f1c-8165-4232-9591-d80799_D2
Normal
N/A
cfb4831f-e9ee-4e11-80fb-958f6f_D2
Tumor
N/A
f9d6fb1b-988e-4D88-9272-cc672f_D8
Tumor
N/A
2666323d-522f-4f0a-823c-ff8866_D2
Normal
N/A
8c73f3a5-fea8-4942-90c0-966f66_D3
Tumor
N/A
4cdeecb5-19fb-493c-91f5-eb0efc_D3
Tumor
N/A
88c621d7-7fb3-4825-abbe-82ae4c_D2
Normal
N/A
067db520-1b1f-4569-9414-e37a6e_D2
Normal
N/A
23e938d0-92b8-4aea-90c1-4385df_D2
Normal
N/A
21cab01c-e968-42cc-9651-1e53c0_D3
Tumor
N/A
76498650-fdbf-4f5d-a19a-cce9a2_D2
Normal
N/A
dfdf03a6-c324-4d8c-a909-ea7345_D2
Tumor
N/A
a5c8bf1d-776c-406f-82a3-2d9ce6_D2
Normal
N/A
a467b905-fc0b-427b-8753-6d38dd_D3
Tumor
N/A
f6afe41c-111d-4818-8485-fe95e0_D2
Tumor
N/A
b6b41ba2-6415-41aa-b5f5-4d47db_D2
Normal
N/A
3d797911-d476-436f-9cce-33e20c_D8
Tumor
N/A
b4e91300-405e-4239-b8da-5e1a42_D2
Tumor
N/A
71b2c1cc-0a31-4ca8-8beb-251e17_D2
Normal
N/A
9bf309bc-0fb6-4060-aba2-888eb3_D2
Tumor
N/A
0630ecb0-b664-4e75-bb3c-fb62ee_D3
Tumor
N/A
176d1b96-8c6e-44fe-8a32-e15194_D2
Normal
N/A
8980bb9d-65c1-41cb-9f90-dddd5f_D2
Normal
N/A
b871c0c1-a97b-4ac1-887c-0317b6_D2
Normal
N/A
e515eb5c-8005-416a-9b42-59de9d_D8
Tumor
N/A
cd6a4013-2958-44b9-a4f1-45c9e4_D2
Tumor
N/A
d80408d6-598d-4411-ab34-eb2545_D2
Normal
N/A
799893aa-d523-4a08-9ea7-611cca_D3
Tumor
N/A
1ab06c24-ffc0-4323-a0cc-e9f5c5_D2
Tumor
N/A
0aef1fe8-ca61-4113-81d0-d82ee7_D2
Tumor
N/A
a84149b1-8453-45f0-8400-d7b12f_D2
Normal
N/A
41a04113-2061-4923-bca5-da586c_D2
Normal
N/A
cc271b3d-ed33-481f-9d23-15f2f6_D2
Normal
N/A
df479b07-bbf6-472d-a580-c3fd0c_D2
Normal
N/A
a313f6ef-5994-4d49-9e66-c26911_D2
Normal
N/A
4bb08fad-fa5e-471e-978b-6b09ab_D2
Tumor
N/A
6b0a3188-d8ca-4d50-a377-a8fe4c_D2
Normal
N/A
c8694e31-2c8f-4eb6-a7ef-a137d9_D3
Tumor
N/A
019cd0c0-733d-4b25-90e3-d54ce0_D2
Normal
N/A
1f79fed9-f0d4-4c45-acd2-ea1441_D2
Normal
N/A
fc9b09af-23b8-4ffe-b6c6-41236d_D2
Normal
N/A
e1cd3d70-132b-452f-ba10-026721_D2
Tumor
N/A
92c1ebb5-ac1d-4bf5-a14f-516e1d_D3
Tumor
N/A
3a17283c-a0f4-4514-956b-080d11_D2
Normal
N/A
66b57abc-0d49-46bb-a390-0e11a9_D2
Tumor
N/A
efee6bb9-69dd-46c2-85b3-b55962_D2
Normal
N/A
02cde0c0-6840-495b-9b11-007d82_D2
Normal
N/A
974e136f-7020-4a38-b9c1-094df9_D2
Normal
N/A
903d5fe0-970a-47be-a97f-3cc914_D2
Normal
N/A
c9730cb4-b52c-4ca8-9652-4509d0_D2
Tumor
N/A
5cf5e61d-21ff-4678-9126-14e9bb_D2
Normal
N/A
f5ed5ebc-881d-456a-80d7-42c9e7_D2
Normal
N/A
cbd0e774-c741-4753-9c9e-391a7d_D2
Normal
N/A
1136008b-97ce-49b0-bf24-abbea6_D2
Normal
N/A
5347d2ce-df0c-4d81-a3e2-22db11_D2
Normal
N/A
da95f6f8-be46-4ed8-a493-2c99f0_D2
Normal
N/A
694e8df1-d9ee-473b-bec1-4f9237_D2
Normal
N/A
6d9f8b06-f28c-4e9b-823b-33ebb7_D2
Normal
N/A
820a3f08-5bb1-44b3-a133-ee167e_D2
Tumor
N/A
bed27f66-ef3b-4868-b4ad-205018_D2
Normal
N/A
3765c09a-fff7-4b37-bf2b-452b23_D2
Normal
N/A
411d9597-c785-4de5-b449-29a80d_D2
Normal
N/A
0d5554d1-1653-4589-a44f-43113e_D2
Normal
N/A
b3696374-c6c0-49dd-833e-596e26_D2
Normal
N/A
66b829db-1cdd-460d-b2f3-0e9ca9_D3
Tumor
N/A
325b5314-6f3c-4d79-9b36-4e7ded_D2
Normal
N/A
8960a27e-69d8-4ec8-a795-c6cf8a_D3
Tumor
N/A
43192517-085e-450e-9481-0a6713_D3
Tumor
N/A
01d1ffca-4235-4dfe-bf62-56f71d_D3
Tumor
N/A
a27cf22d-836e-49a7-802f-47c1db_D2
Normal
N/A
372c900a-fced-4eef-9dc4-7282ec_D2
Tumor
N/A
e14c2cbe-eca0-4745-97f6-8f27bd_D2
Normal
N/A
359f5c81-2575-497e-8630-e4866f_D2
Normal
N/A
da747cee-5026-4923-af63-ad9f81_D2
Normal
N/A
cd3a9d59-bf13-48f3-ae97-bdbca4_D2
Normal
N/A
c6ae57a7-65a0-438e-bae2-97b1c8_D3
Tumor
N/A
05a33362-82bb-48ac-8feb-ad2ea1_D2
Tumor
N/A
206f3bd9-f62c-4663-8fdb-5b731b_D2
Normal
N/A
d6584b4a-ca99-4a2a-8b4e-c8b22e_D3
Tumor
N/A
db3f5ad9-d14d-4126-a3e7-d80faa_D3
Tumor
N/A
c9f0f144-47f3-4d64-b29f-bcedfa_D2
Normal
N/A
7cc7f69f-99f5-4b23-a9e0-ba0dc8_D8
Tumor
N/A
87408d9e-4029-4e8f-b14c-8efc04_D3
Tumor
N/A
4b263734-430f-41dc-a296-8691f0_D3
Tumor
N/A
515040a4-bbfb-4a15-9e53-e7b6e6_D2
Normal
N/A
bd67de01-ad7d-431a-9ad6-4dd5a1
Tumor
N/A
a243b765-61ab-4aa6-88e1-226896_D2
Normal
N/A
e74089a9-f78c-4ffe-8174-aef71b_D2
Normal
N/A
b4dd4a04-5eda-43dd-8298-215b07_D3
Tumor
N/A
c65afd57-530c-4366-b2c8-463a46_D2
Tumor
N/A
4c9dcc8c-ccdc-4336-8e23-107feb_D2
Normal
N/A
7fd2eea8-bf99-4f97-8b9e-fb703f_D2
Normal
N/A
348f6009-e1be-44d2-a093-9ca844_D2
Normal
N/A
803736b3-9ca9-4f9f-bdfe-8783e3_D3
Tumor
N/A
7478980a-60fb-4f5e-aa1c-2d7941_D2
Normal
N/A
5f823547-ee16-45b7-a6a0-ef25d6_D3
Tumor
N/A
0f238226-864c-4de0-8c61-01e729_D2
Tumor
N/A
b605fafc-f7dd-44cc-9c86-da04e3_D2
Tumor
N/A
2cc46aec-6142-4fb9-aca5-c442b9_D2
Normal
N/A
7784e2e5-c0e1-4b85-8cc1-7faac8_D2
Normal
N/A
f69deaeb-6b6f-4c61-8900-fd0f26_D3
Tumor
N/A
dffcac99-9eac-4717-aeb6-f4a2e7_D8
Tumor
N/A
5da00abd-5fa7-4deb-95f1-7982e0_D3
Tumor
N/A
c2c53076-b5db-4b7d-983c-a35740_D3
Tumor
N/A
3e8019e8-125f-4615-a1fa-a448e9_D2
Normal
N/A
2f8b02e4-1848-4abc-a95e-dd9eb5_D3
Tumor
N/A
1bf00d93-240f-47e8-8055-f546b0_D2
Normal
N/A
f635496c-0046-4ecd-89bc-7a4f33_D2
Tumor
N/A
bda3787a-1397-4716-bb17-4992a8_D2
Normal
N/A
43bc845e-d22e-4c10-b3e8-bc54e6_D2
Normal
N/A
321fb3b2-ebb6-4ea5-b737-081264_D2
Tumor
N/A
2d266d2d-4bb3-436c-a3e7-06acb2_D3
Tumor
N/A
65867ab1-5eab-44a8-b2bb-d27263_D2
Normal
N/A
059a7065-3a5f-4eea-97e5-85ab01_D2
Normal
N/A
1563ef63-d2e6-406f-adc1-255949_D3
Tumor
N/A
695b0b00-a86b-43c0-a6c8-50a840_D3
Tumor
N/A
92f7419c-c57a-4b50-bdc9-4d09ca_D2
Tumor
N/A
41ee934e-f7a3-4ef5-8a83-e2ac56_D2
Tumor
N/A
1fbb1add-4660-4ec1-b8c2-360f9f_D2
Normal
N/A
211cbcef-cb1f-4c80-a1c8-a76d3c_D2
Normal
N/A
377cdd37-d1bd-4042-997e-478a0f_D2
Normal
N/A
233ec093-9a30-4ef4-a12c-91757e_D2
Normal
N/A
0f757044-9bc8-4ed4-90f3-e0a49a_D3
Tumor
N/A
0c330883-ab58-4a5a-bff7-07d283_D2
Normal
N/A
d3078fa8-0692-411f-8441-0c7c48_D8
Tumor
N/A
37219a7c-6fe2-4684-a494-d0be08_D2
Tumor
N/A
5271982c-5de1-4d6e-b414-b1f3ef_D2
Tumor
N/A
46dfc1e4-0110-4d9f-888e-6a29ab_D2
Normal
N/A
6e0d04fc-e6a8-41ed-b6f3-45537d_D2
Normal
N/A
Show allShow less
COLORECTAL CANCER - Protein expressioni
A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here.
Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.
Antibody stainingi
Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells.
Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.